David Anderson

David Anderson

Company: VBI Vaccines

Job title: Chief Scientific Officer

Seminars:

Chair’s Closing Remarks & End of Conference 4:30 pm

Read more

day: Day Two

Chair’s Opening Remarks 8:25 am

Read more

day: Day Two

Clinical Trial Design Considerations for a Combination Therapy with Multiple Mechanisms of Action to Achieve a Functional Cure 11:00 am

• What can we learn from existing clinical collaborations and clinical data to inform combination therapy for chronic HBV? • Establishing effective biomarkers to measure efficacy • Constructing multi-arm trials to evaluate different combinationsRead more

day: Day One

Panel Discussion: What, When & How? Pursuing Combination Therapy to Improve Durable Efficacy & Decrease Viral Breakthrough 8:30 am

• Sequencing multiple mechanisms of action acting on immune and viral targets to optimize therapeutic effect • Identifying effective combinations to achieve treatment with finite durations • Measuring toxicity and adverse events in combination therapy for HBVRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.